E N D
Improved Survival of Hepatocellular Carcinoma (HCC) in HIV-Infected Patients with Undetectable HIV RNAOral Poster PresentationTuesday, 20 July 2010Emma Page*, Eugenia Vispo, David E. Kaplan, Luciana Kikuchi, Marina Núñez, Mark Nelson, Pablo Barreiro, Jorge Daruich, Kristen Marks, Rena Fox, Morris Sherman, Massimo Puoti, Norbert Bräu. Liver Cancer in HIV Study Group * Chelsea & Westminster Hospital * Imperial College, London
HCC in HIV – HIV RNA Level and Survival: Methods n=115 • Retrospective • Inclusion Criteria: HIV+, HCV Ab, AASLD 2005 N age Male CD4 HCV date Dx no ETOH Screening CTP: C Undetectable: HIV RNA < 400 c/ml 68 (59%) 51.4 63 (93%) 319 49 (72%) Jul ’05 26 (40%) 42 (62%) 3 (4.4%) Detectable: HIV RNA > 400 c/ml 47 (41%) 51.5 43 (92%) 320 36 (77%) May ’03 8 (18%) 21 (45%) 7 (15%)
HCC in HIV – HIV RNA Level and Survival Tumor Characteristics HCC Therapy Emma Page for Liver Cancer in HIV Study Group, AIDS 2010, Vienna
HCC in HIV – HIV RNA Level and Survival: Survival All Patients No HCC Therapy Effective, Non-Curative Therapy Potentially Curative Therapy Emma Page for Liver Cancer in HIV Study Group, AIDS 2010, Vienna
Thank you much for your kind attention Emma Page for Liver Cancer in HIV Study Group, AIDS 2010, Vienna